[Cardiovascular changes during alpha-2 agonist treatment of opiate withdrawal syndrome].
Rubio
G
G
López-Muñoz
F
F
Alamo
C
C
Arias
A
A
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D003000:Clonidine / Q000494:pharmacology; D016316:Guanfacine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects*; D003932:Heroin / Q000009:adverse effects*; D006556:Heroin Dependence / Q000628:therapy*; D051381:Rats; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D013997:Time Factors
D000316:Adrenergic alpha-Agonists; D016316:Guanfacine; D003932:Heroin; D003000:Clonidine
Alteraciones cardiovasculares durante el tratamiento del síndrome de abstinencia a opiáceos con fármacos alfa-2 agonistas.